“Because breast parenchyma may reflect the biologic risk factors associated with breast cancer development, yielding the stromal parenchyma as an indicator of precancer, the combination of parenchyma and tumor characteristics may provide a stronger predictive model of malignancy,” lead author Hui Li, PhD, and colleagues wrote in a new study published in Radiology

Since 1989, the combination of mammography and improved breast cancer treatment has averted hundreds of thousands of breast cancer mortalities for U.S. women, according to new research published online Feb. 11 in the journal Cancer.

Despite the best current recommendations advocating women avoid mammograms before elective breast surgery, a large number of women still undergo pre-surgical screening, reported authors of a study published in JAMA Surgery. The unnecessary imaging may drive up healthcare costs and lead to unneeded tests.

Previously established frameworks for creating breast cancer screening bundled payment models are achievable, according to a new study published in the Journal of the American College of Radiology. The approaches could also incorporate the rise of digital breast tomosynthesis (DBT).

Implementing three-dimensional (3D) digital breast tomosynthesis (DBT) with standard digital mammography (DM) can reduce the number of patients committed to short-term follow-up screening, according to research published online Jan. 19 in Academic Radiology.

Pairing breast MRI with a test that characterizes breast cancer genes can lead to a more personalized treatment approach for patients with ductal carcinoma in situ (DCIS), reported authors of a recent study published in JAMA Oncology.

Stationary digital breast tomosynthesis (sDBT) improved radiologists’ accuracy in detecting malignancies and was favored over mammography, reported authors of a Jan. 16 study published in Academic Radiology.

Edward-Elmhurst Health is the first health system in the Chicagoland area to offer molecular breast imaging and comes just in time for Illinois' newly enacted breast density notification law, according to a report published Jan. 14 by Crain’s Chicago Business.

Kheiron Medical, an artificial intelligence (AI) medical imaging startup based in London, is the latest company to announce its research efforts in using AI to identify signs of breast cancer from mammograms and help alleviate the U.K.’s current radiologist shortage, according to a recent article by the Financial Times.

The Society of Breast Imaging (SBI) addressed the importance of diversity in breast imaging in a recent statement published online Jan. 9, stating that breast cancer does not affect all ethnic and socioeconomic populations equally.

Although many insurance providers have invested in price calculators for patients to determine out-of-pocket costs, one Philadelphia woman discovered they may severely underestimate actual prices for services, according to a recent report by The Philadelphia Inquirer.

Revamped guidelines on screening for breast cancer promote shared decision-making between women and their doctors. The new instructions were released by the Canadian Task Force on Preventative Health Care and published in the Canadian Medical Association Journal.